register

News & Trends - Pharmaceuticals

Pharma embraces new sales channel

Health Industry Hub | April 16, 2019 |

Leading healthcare media company Australian Doctor Group (ADG) announced today that its new digital sales channel, AccessPlus has “exceeded expectations” with 12 brands signed-on to the platform across a range of therapeutic areas, including respiratory, diabetes, weight loss, dermatology, smoking cessation, female sexual health, mental health, and oncology.

Launched late last year, AccessPlus is a channel that allows pharmaceutical marketers to access and engage with doctors in a novel way.

Australian Doctor Group now boasts a 41,000-plus HCP subscriber base of highly engaged prescribers, predominantly GPs.

ADG’s commercial director, Martha Peacock says AccessPlus fills a “glaring gap” in the market. “With over 39% of GPs no longer seeing sales reps, pharma has been desperate to find a new way to access and engage doctors cost-effectively,” Ms Peacock said. “In many ways AccessPlus mirrors and supports what the rep does in the field by educating, informing and promoting, yet it is in the data, segmentation and insights that the platform truly shines.

“Our pharma clients have never had access to this type of data before. It’s like gold to them.”

According to Ms Peacock, AccessPlus is a flexible platform that suits brands of different sizes. The early adopters have used AccessPlus for a range of brand objectives: To increase brand engagement, to access hard-to-reach doctors with a succinct brand ‘sell’, to drive quick and broad brand awareness at launch, to promote private-script drugs in a cost-effective way, to drive user acquisition to a pharma website, and to augment sales and marketing activity when the fieldforce has been reduced or cut.

“Our clients are already seeing an ROI at a fraction of the cost of a face-to-face sales rep visit, and they are gaining access to HCPs they couldn’t reach before” she said.

“AccessPlus affords marketers previously impossible cost and strategic dividends.”

Source: Australian Doctor Group is the leading healthcare publisher in Australia, #1 across both print and digital with General Practitioners.


News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]

More


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]

More


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]

More


ESG

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]

More


This content is copyright protected. Please subscribe to gain access.